vs
Side-by-side financial comparison of Forestar Group Inc. (FOR) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $273.0M, roughly 1.8× Forestar Group Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.6%, a 1.2% gap on every dollar of revenue. On growth, Forestar Group Inc. posted the faster year-over-year revenue change (9.0% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -9.6%).
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FOR vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $273.0M | $493.8M |
| Net Profit | $15.4M | $33.7M |
| Gross Margin | 20.1% | — |
| Operating Margin | 7.6% | 9.9% |
| Net Margin | 5.6% | 6.8% |
| Revenue YoY | 9.0% | -1.7% |
| Net Profit YoY | -6.7% | 10.5% |
| EPS (diluted) | $0.30 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $273.0M | $493.8M | ||
| Q3 25 | $670.5M | $492.9M | ||
| Q2 25 | $390.5M | $468.8M | ||
| Q1 25 | $351.0M | $458.4M | ||
| Q4 24 | $250.4M | $502.4M | ||
| Q3 24 | $551.3M | $511.2M | ||
| Q2 24 | $318.4M | $504.3M | ||
| Q1 24 | $333.8M | $495.1M |
| Q4 25 | $15.4M | $33.7M | ||
| Q3 25 | $86.9M | $71.7M | ||
| Q2 25 | $32.9M | $39.3M | ||
| Q1 25 | $31.6M | $20.7M | ||
| Q4 24 | $16.5M | $30.5M | ||
| Q3 24 | $81.5M | $19.4M | ||
| Q2 24 | $38.7M | $-153.0M | ||
| Q1 24 | $45.0M | $4.0M |
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
| Q4 25 | 7.6% | 9.9% | ||
| Q3 25 | 16.9% | 13.8% | ||
| Q2 25 | 11.2% | 12.8% | ||
| Q1 25 | 11.6% | 7.0% | ||
| Q4 24 | 8.7% | 7.8% | ||
| Q3 24 | 19.7% | 6.6% | ||
| Q2 24 | 16.2% | -31.3% | ||
| Q1 24 | 17.6% | 3.2% |
| Q4 25 | 5.6% | 6.8% | ||
| Q3 25 | 13.0% | 14.5% | ||
| Q2 25 | 8.4% | 8.4% | ||
| Q1 25 | 9.0% | 4.5% | ||
| Q4 24 | 6.6% | 6.1% | ||
| Q3 24 | 14.8% | 3.8% | ||
| Q2 24 | 12.2% | -30.3% | ||
| Q1 24 | 13.5% | 0.8% |
| Q4 25 | $0.30 | $0.40 | ||
| Q3 25 | $1.70 | $0.84 | ||
| Q2 25 | $0.65 | $0.46 | ||
| Q1 25 | $0.62 | $0.24 | ||
| Q4 24 | $0.32 | $0.37 | ||
| Q3 24 | $1.59 | $0.23 | ||
| Q2 24 | $0.76 | $-1.84 | ||
| Q1 24 | $0.89 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $211.7M | $375.2M |
| Total DebtLower is stronger | $793.2M | $570.5M |
| Stockholders' EquityBook value | $1.8B | $865.9M |
| Total Assets | $3.2B | $2.2B |
| Debt / EquityLower = less leverage | 0.44× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $211.7M | $375.2M | ||
| Q3 25 | $379.2M | $340.1M | ||
| Q2 25 | $189.2M | $224.7M | ||
| Q1 25 | $174.3M | $99.0M | ||
| Q4 24 | $132.0M | $229.9M | ||
| Q3 24 | $481.2M | $103.8M | ||
| Q2 24 | $359.2M | $19.4M | ||
| Q1 24 | $416.2M | $8.0M |
| Q4 25 | $793.2M | $570.5M | ||
| Q3 25 | $802.7M | $577.2M | ||
| Q2 25 | $872.8M | $583.9M | ||
| Q1 25 | $872.5M | $590.5M | ||
| Q4 24 | $806.8M | $597.1M | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
| Q4 25 | $1.8B | $865.9M | ||
| Q3 25 | $1.8B | $890.7M | ||
| Q2 25 | $1.7B | $833.8M | ||
| Q1 25 | $1.6B | $789.2M | ||
| Q4 24 | $1.6B | $764.9M | ||
| Q3 24 | $1.6B | $732.5M | ||
| Q2 24 | $1.5B | $706.5M | ||
| Q1 24 | $1.5B | $856.2M |
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.1B | $2.2B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.2B | ||
| Q3 24 | $2.8B | $2.1B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.6B | $2.2B |
| Q4 25 | 0.44× | 0.66× | ||
| Q3 25 | 0.45× | 0.65× | ||
| Q2 25 | 0.52× | 0.70× | ||
| Q1 25 | 0.53× | 0.75× | ||
| Q4 24 | 0.50× | 0.78× | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-157.0M | $114.1M |
| Free Cash FlowOCF − Capex | $-157.1M | — |
| FCF MarginFCF / Revenue | -57.5% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -10.19× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $93.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-157.0M | $114.1M | ||
| Q3 25 | $256.3M | $137.3M | ||
| Q2 25 | $15.8M | $137.2M | ||
| Q1 25 | $-19.8M | $-117.5M | ||
| Q4 24 | $-450.0M | $133.0M | ||
| Q3 24 | $119.2M | $91.8M | ||
| Q2 24 | $-61.7M | $107.0M | ||
| Q1 24 | $-59.2M | $-125.2M |
| Q4 25 | $-157.1M | — | ||
| Q3 25 | $255.6M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $118.4M | — | ||
| Q2 24 | $-62.3M | — | ||
| Q1 24 | $-59.8M | — |
| Q4 25 | -57.5% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.5% | — | ||
| Q2 24 | -19.6% | — | ||
| Q1 24 | -17.9% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | -10.19× | 3.39× | ||
| Q3 25 | 2.95× | 1.91× | ||
| Q2 25 | 0.48× | 3.49× | ||
| Q1 25 | -0.63× | -5.66× | ||
| Q4 24 | -27.27× | 4.36× | ||
| Q3 24 | 1.46× | 4.72× | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
